Global COVID-19 RNA Vaccine Market Size, Status and Forecast 2020-2026

Global COVID-19 RNA Vaccine Market Size, Status and Forecast 2020-2026

May 2020 QYResearch ICT98 Pages Price :
$ 3900
This report focuses on the global COVID-19 RNA Vaccine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the COVID-19 RNA Vaccine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
MODERNA
CureVac
Zydus Cadila
BioNTech
Stermirna
...

Market segment by Type, the product can be split into
Being Developed
Preclinical
Clinical I
Clinical II
Market segment by Application, split into
Pharmaceutical And Biotechnology Companies
Hospital
Academic And Research Organizations
Other

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global COVID-19 RNA Vaccine status, future forecast, growth opportunity, key market and key players.
To present the COVID-19 RNA Vaccine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of COVID-19 RNA Vaccine are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by COVID-19 RNA Vaccine Revenue
1.4 Market Analysis by Type
1.4.1 Global COVID-19 RNA Vaccine Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Being Developed
1.4.3 Preclinical
1.4.4 Clinical I
1.4.5 Clinical II
1.5 Market by Application
1.5.1 Global COVID-19 RNA Vaccine Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical And Biotechnology Companies
1.5.3 Hospital
1.5.4 Academic And Research Organizations
1.5.5 Other
1.6 Coronavirus Disease 2019 (Covid-19): COVID-19 RNA Vaccine Industry Impact
1.6.1 How the Covid-19 is Affecting the COVID-19 RNA Vaccine Industry
1.6.1.1 COVID-19 RNA Vaccine Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and COVID-19 RNA Vaccine Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for COVID-19 RNA Vaccine Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 Executive Summary
2.1 COVID-19 RNA Vaccine Market Perspective (2015-2026)
2.2 COVID-19 RNA Vaccine Growth Trends by Regions
2.2.1 COVID-19 RNA Vaccine Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 COVID-19 RNA Vaccine Historic Market Share by Regions (2018-2019)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers

3 Competition Landscape by Key Players
3.1 COVID-19 RNA Vaccine Revenue by Players (2019-2020)
3.2 COVID-19 RNA Vaccine Key Players Head office and Area Served
3.3 Key Players COVID-19 RNA Vaccine Product/Solution/Service
3.4 Date of Enter into COVID-19 RNA Vaccine Market
3.5 Key Players COVID-19 RNA Vaccine Funding/Investment Analysis
3.6 Global Key Players COVID-19 RNA Vaccine Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Global COVID-19 RNA Vaccine Market Size by Type (2019-2026)

5 Global COVID-19 RNA Vaccine Market Size by Application (2019-2026)

6 North America
6.1 North America COVID-19 RNA Vaccine Market Forecast (2019-2026)
6.2 COVID-19 RNA Vaccine Key Players in North America (2019-2020)
6.3 North America COVID-19 RNA Vaccine Market Size by Type (2015-2020)
6.4 North America COVID-19 RNA Vaccine Market Size by Application (2015-2020)

7 Europe
7.1 Europe COVID-19 RNA Vaccine Market Forecast (2019-2026)
7.2 COVID-19 RNA Vaccine Key Players in Europe (2019-2020)
7.3 Europe COVID-19 RNA Vaccine Market Size by Type (2015-2020)
7.4 Europe COVID-19 RNA Vaccine Market Size by Application (2015-2020)

8 China
8.1 China COVID-19 RNA Vaccine Market Forecast (2019-2026)
8.2 COVID-19 RNA Vaccine Key Players in China (2019-2020)
8.3 China COVID-19 RNA Vaccine Market Size by Type (2015-2020)
8.4 China COVID-19 RNA Vaccine Market Size by Application (2015-2020)

9 Japan
9.1 Japan COVID-19 RNA Vaccine Market Forecast (2019-2026)
9.2 COVID-19 RNA Vaccine Key Players in Japan (2019-2020)
9.3 Japan COVID-19 RNA Vaccine Market Size by Type (2015-2020)
9.4 Japan COVID-19 RNA Vaccine Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia COVID-19 RNA Vaccine Market Forecast (2019-2026)
10.2 COVID-19 RNA Vaccine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia COVID-19 RNA Vaccine Market Size by Type (2015-2020)
10.4 Southeast Asia COVID-19 RNA Vaccine Market Size by Application (2015-2020)

11 India
11.1 India COVID-19 RNA Vaccine Market Forecast (2019-2026)
11.2 COVID-19 RNA Vaccine Key Players in India (2019-2020)
11.3 India COVID-19 RNA Vaccine Market Size by Type (2015-2020)
11.4 India COVID-19 RNA Vaccine Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America COVID-19 RNA Vaccine Market Forecast (2019-2026)
12.2 COVID-19 RNA Vaccine Key Players in Central & South America (2019-2020)
12.3 Central & South America COVID-19 RNA Vaccine Market Size by Type (2015-2020)
12.4 Central & South America COVID-19 RNA Vaccine Market Size by Application (2015-2020)

13Key Players Profiles
13.1 MODERNA
13.1.1 MODERNA Company Details
13.1.2 MODERNA Business Overview and Its Total Revenue
13.1.3 MODERNA COVID-19 RNA Vaccine Introduction
13.1.4 MODERNA Revenue in COVID-19 RNA Vaccine Business (2019-2020))
13.1.5 MODERNA Recent Development
13.2 CureVac
13.2.1 CureVac Company Details
13.2.2 CureVac Business Overview and Its Total Revenue
13.2.3 CureVac COVID-19 RNA Vaccine Introduction
13.2.4 CureVac Revenue in COVID-19 RNA Vaccine Business (2019-2020))
13.2.5 CureVac Recent Development
13.3 Zydus Cadila
13.3.1 Zydus Cadila Company Details
13.3.2 Zydus Cadila Business Overview and Its Total Revenue
13.3.3 Zydus Cadila COVID-19 RNA Vaccine Introduction
13.3.4 Zydus Cadila Revenue in COVID-19 RNA Vaccine Business (2019-2020))
13.3.5 Zydus Cadila Recent Development
13.4 BioNTech
13.4.1 BioNTech Company Details
13.4.2 BioNTech Business Overview and Its Total Revenue
13.4.3 BioNTech COVID-19 RNA Vaccine Introduction
13.4.4 BioNTech Revenue in COVID-19 RNA Vaccine Business (2019-2020))
13.4.5 BioNTech Recent Development
13.5 Stermirna
13.5.1 Stermirna Company Details
13.5.2 Stermirna Business Overview and Its Total Revenue
13.5.3 Stermirna COVID-19 RNA Vaccine Introduction
13.5.4 Stermirna Revenue in COVID-19 RNA Vaccine Business (2019-2020))
13.5.5 Stermirna Recent Development

14 Market Dynamics
14.1 Drivers
14.2 Challenges
14.3 Porters Five Forces Analysis
14.4 Market Ecosystem and Value Chain Analysis

15 Key Findings in This Report
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table

List of Tables
Table 1. COVID-19 RNA Vaccine Key Market Segments
Table 2. Key Players Covered: Ranking by COVID-19 RNA Vaccine Revenue
Table 3. Ranking of Global Top COVID-19 RNA Vaccine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global COVID-19 RNA Vaccine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Being Developed
Table 6. Key Players of Preclinical
Table 7. Key Players of Clinical I
Table 8. Key Players of Clinical II
Table 9. COVID-19 Impact Global Market: (Four COVID-19 RNA Vaccine Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for COVID-19 RNA Vaccine Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for COVID-19 RNA Vaccine Players to Combat Covid-19 Impact
Table 14. Global COVID-19 RNA Vaccine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global COVID-19 RNA Vaccine Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global COVID-19 RNA Vaccine Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global COVID-19 RNA Vaccine Market Share by Regions 2019-2026
Table 18. Market Top Trends
Table 19. Market Use Cases
Table 20. Global COVID-19 RNA Vaccine Revenue by Players (2019-2020) (Million US$)
Table 21. Global COVID-19 RNA Vaccine Market Share by Players (2019-2020)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players COVID-19 RNA Vaccine Product Solution and Service
Table 24. Date of Enter into COVID-19 RNA Vaccine Market
Table 25. Global Key Players COVID-19 RNA Vaccine Funding/Investment Analysis (Million USD)
Table 26. Global Key Players COVID-19 RNA Vaccine Valuation & Market Capitalization (Million USD)
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global COVID-19 RNA Vaccine Market Size by Type (2019-2026) (Million US$)
Table 29. Global COVID-19 RNA Vaccine Market Size Share by Type (2019-2026)
Table 30. Global COVID-19 RNA Vaccine Market Size by Application (2019-2026) (Million US$)
Table 31. Global COVID-19 RNA Vaccine Market Size Share by Application (2019-2026)
Table 32. North America Key Players COVID-19 RNA Vaccine Revenue (2019-2020) (Million US$)
Table 33. North America Key Players COVID-19 RNA Vaccine Market Share (2019-2020)
Table 34. North America COVID-19 RNA Vaccine Market Size by Type (2019-2026) (Million US$)
Table 35. North America COVID-19 RNA Vaccine Market Share by Type (2019-2026)
Table 36. North America COVID-19 RNA Vaccine Market Size by Application (2019-2026) (Million US$)
Table 37. North America COVID-19 RNA Vaccine Market Share by Application (2019-2026)
Table 38. Europe Key Players COVID-19 RNA Vaccine Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players COVID-19 RNA Vaccine Market Share (2019-2020)
Table 40. Europe COVID-19 RNA Vaccine Market Size by Type (2019-2026) (Million US$)
Table 41. Europe COVID-19 RNA Vaccine Market Share by Type (2019-2026)
Table 42. Europe COVID-19 RNA Vaccine Market Size by Application (2019-2026) (Million US$)
Table 43. Europe COVID-19 RNA Vaccine Market Share by Application (2019-2026)
Table 44. China Key Players COVID-19 RNA Vaccine Revenue (2019-2020) (Million US$)
Table 45. China Key Players COVID-19 RNA Vaccine Market Share (2019-2020)
Table 46. China COVID-19 RNA Vaccine Market Size by Type (2019-2026) (Million US$)
Table 47. China COVID-19 RNA Vaccine Market Share by Type (2019-2026)
Table 48. China COVID-19 RNA Vaccine Market Size by Application (2019-2026) (Million US$)
Table 49. China COVID-19 RNA Vaccine Market Share by Application (2019-2026)
Table 50. Japan Key Players COVID-19 RNA Vaccine Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players COVID-19 RNA Vaccine Market Share (2019-2020)
Table 52. Japan COVID-19 RNA Vaccine Market Size by Type (2019-2026) (Million US$)
Table 53. Japan COVID-19 RNA Vaccine Market Share by Type (2019-2026)
Table 54. Japan COVID-19 RNA Vaccine Market Size by Application (2019-2026) (Million US$)
Table 55. Japan COVID-19 RNA Vaccine Market Share by Application (2019-2026)
Table 56. Southeast Asia Key Players COVID-19 RNA Vaccine Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players COVID-19 RNA Vaccine Market Share (2019-2020)
Table 58. Southeast Asia COVID-19 RNA Vaccine Market Size by Type (2019-2026) (Million US$)
Table 59. Southeast Asia COVID-19 RNA Vaccine Market Share by Type (2019-2026)
Table 60. Southeast Asia COVID-19 RNA Vaccine Market Size by Application (2019-2026) (Million US$)
Table 61. Southeast Asia COVID-19 RNA Vaccine Market Share by Application (2019-2026)
Table 62. India Key Players COVID-19 RNA Vaccine Revenue (2019-2020) (Million US$)
Table 63. India Key Players COVID-19 RNA Vaccine Market Share (2019-2020)
Table 64. India COVID-19 RNA Vaccine Market Size by Type (2019-2026) (Million US$)
Table 65. India COVID-19 RNA Vaccine Market Share by Type (2019-2026)
Table 66. India COVID-19 RNA Vaccine Market Size by Application (2019-2026) (Million US$)
Table 67. India COVID-19 RNA Vaccine Market Share by Application (2019-2026)
Table 68. Central & South America Key Players COVID-19 RNA Vaccine Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players COVID-19 RNA Vaccine Market Share (2019-2020)
Table 70. Central & South America COVID-19 RNA Vaccine Market Size by Type (2019-2026) (Million US$)
Table 71. Central & South America COVID-19 RNA Vaccine Market Share by Type (2019-2026)
Table 72. Central & South America COVID-19 RNA Vaccine Market Size by Application (2019-2026) (Million US$)
Table 73. Central & South America COVID-19 RNA Vaccine Market Share by Application (2019-2026)
Table 74. MODERNA Company Details
Table 75. MODERNA Business Overview
Table 76. MODERNA Product
Table 77. Company Description and Business Overview
Table 78. MODERNA COVID-19 RNA Vaccine Product
Table 79. MODERNA Revenue in COVID-19 RNA Vaccine Business 2019 and 2020 (Million US$)
Table 80. MODERNA Recent Development
Table 81. CureVac Company Details
Table 82. CureVac Business Overview
Table 83. CureVac Product
Table 84. Company Description and Business Overview
Table 85. CureVac COVID-19 RNA Vaccine Product
Table 86. CureVac Revenue in COVID-19 RNA Vaccine Business 2019 and 2020 (Million US$)
Table 87. CureVac Recent Development
Table 88. Zydus Cadila Company Details
Table 89. Zydus Cadila Business Overview
Table 90. Zydus Cadila Product
Table 91. Company Description and Business Overview
Table 92. Zydus Cadila COVID-19 RNA Vaccine Product
Table 93. Zydus Cadila Revenue in COVID-19 RNA Vaccine Business 2019 and 2020 (Million US$)
Table 94. Zydus Cadila Recent Development
Table 95. BioNTech Company Details
Table 96. BioNTech Business Overview
Table 97. BioNTech Product
Table 98. Company Description and Business Overview
Table 99. BioNTech COVID-19 RNA Vaccine Product
Table 100. BioNTech Revenue in COVID-19 RNA Vaccine Business 2019 and 2020 (Million US$)
Table 101. BioNTech Recent Development
Table 102. Stermirna Company Details
Table 103. Stermirna Business Overview
Table 104. Stermirna Product
Table 105. Company Description and Business Overview
Table 106. Stermirna COVID-19 RNA Vaccine Product
Table 107. Stermirna Revenue in COVID-19 RNA Vaccine Business 2019 and 2020 (Million US$)
Table 108. Stermirna Recent Development
Table 109. Company Description and Business Overview
Table 110. Company Description and Business Overview
Table 111. Company Description and Business Overview
Table 112. Company Description and Business Overview
Table 113. Company Description and Business Overview
Table 114. Company Description and Business Overview
Table 115. Company Description and Business Overview
Table 116. Company Description and Business Overview
Table 117. Company Description and Business Overview
Table 118. Company Description and Business Overview
Table 119. Company Description and Business Overview
Table 120. Company Description and Business Overview
Table 121. Company Description and Business Overview
Table 122. Company Description and Business Overview
Table 123. Company Description and Business Overview
Table 124. Company Description and Business Overview
Table 125. Company Description and Business Overview
Table 126. Company Description and Business Overview
Table 127. Company Description and Business Overview
Table 128. Company Description and Business Overview
Table 129. Company Description and Business Overview
Table 130. Company Description and Business Overview
Table 131. Company Description and Business Overview
Table 132. Company Description and Business Overview
Table 133. Company Description and Business Overview
Table 134. Company Description and Business Overview
Table 135. Company Description and Business Overview
Table 136. Company Description and Business Overview
Table 137. Company Description and Business Overview
Table 138. Company Description and Business Overview
Table 139. Company Description and Business Overview
Table 140. Company Description and Business Overview
Table 141. Company Description and Business Overview
Table 142. Company Description and Business Overview
Table 143. Company Description and Business Overview
Table 144. Key Drivers: Impact Analysis (2021-2026)
Table 145. Key Opportunities
Table 146. Key Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Global COVID-19 RNA Vaccine Market Share by Type: 2020 VS 2026
Figure 2. Being Developed Features
Figure 3. Preclinical Features
Figure 4. Clinical I Features
Figure 5. Clinical II Features
Figure 6. Global COVID-19 RNA Vaccine Market Share by Application: 2020 VS 2026
Figure 7. Pharmaceutical And Biotechnology Companies Case Studies
Figure 8. Hospital Case Studies
Figure 9. Academic And Research Organizations Case Studies
Figure 10. Other Case Studies
Figure 11. COVID-19 RNA Vaccine Report Years Considered
Figure 12. Global COVID-19 RNA Vaccine and Growth Rate (2019-2026) (Million US$)
Figure 13. Global COVID-19 RNA Vaccine Market Share by Regions (2019-2026)
Figure 14. Global COVID-19 RNA Vaccine Market Share by Players in 2019
Figure 15. Global COVID-19 RNA Vaccine Market Size Market Share by Type (2019-2026)
Figure 16. Global COVID-19 RNA Vaccine Market Size Market Share by Application (2019-2026)
Figure 17. North America COVID-19 RNA Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 18. Europe COVID-19 RNA Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 19. China COVID-19 RNA Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 20. Japan COVID-19 RNA Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 21. Southeast Asia COVID-19 RNA Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 22. India COVID-19 RNA Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 23. Central & South America COVID-19 RNA Vaccine Market Size YoY Growth (2019-2026) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed

Ask for discount before buying this report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Country :
  • Your Requirement
  • Security Code *
* denotes fields which must be completed

Buy This Report


Select License Type :

$ 3900
$ 5850

Do you wish to check sample of this report?

Have Query?


Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top